Lung Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapies for underserved, life-threatening lung conditions.
Location: United States, Texas, Austin
Mentions in press and media 10
| Date | Title | Description |
| 31.10.2023 | Aileron Therapeutics Acquires Lung Therapeutics | Aileron Therapeutics, Inc. (NASDAQ: ALRN) acquired Lung Therapeutics, Inc., an Austin, Texas-based biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications that have no a... |
| 05.06.2019 | Lung Therapeutics raises $36M to trial pleural effusion drug | Lung Therapeutics has raised a $36 million series C round to take a treatment for a serious complication of pneumonia through phase 2 studies. Texas-based Lung Therapeutics is built on the research of Steven Idell, a pulmonologist who worke... |
| 04.06.2019 | Lung Therapeutics Raises $36M in Series C Financing | Lung Therapeutics, Inc., an Austin, TX-based clinical stage biopharmaceutical company developing novel therapeutics for orphan, pulmonary indications, closed a $36m Series C financing round. Bios Partners participated in the Series C round.... |
| 08.06.2017 | Lung Therapeutics Raises $14.3M Series B | Lung Therapeutics, Inc., a clinical stage pharmaceutical company developing novel therapeutics for niche, orphan drug indications in fibrosis, lung injury and disease, announced today the successful completion of a $14.3 million Series B fi... |
| 07.06.2017 | Term Sheet — Wednesday, June 7 | 500 Hello, it’s Fortune 500 day! The 2017 list is live here. For 63 years, this list has ranked the largest companies in the U.S. by revenue. Paid Content You can't secure what you can't see From ExtraHop KKR got rather dramatically knocked... |
| 07.06.2017 | Lung Therapeutics Raises $14.3M in Series B Financing | Lung Therapeutics, Inc., an Austin, Texas-based clinical stage pharmaceutical company developing novel therapeutics for niche, orphan drug indications in fibrosis, lung injury and disease, closed a $14.3m Series B financing. The round was l... |
| 06.06.2017 | Lung Therapeutics Receives $14.3M | AUSTIN, TX, Lung Therapeutics announced today the successful completion of a $14.3 million Series B financing. >> Click here for more funding data on Lung Therapeutics >> To export Lung Therapeutics funding data to PDF and E... |
| 06.06.2017 | Lung Therapeutics breathes easy with $14M series B | Texas startup Lung Therapeutics has got off a $14.3 million series B round as it eyes the cash boost for its trials in fibrosis, lung injury and disease. Specifically, the new proceeds will help fund its experimental phase 1 therapy LTI-01 ... |
| 13.01.2016 | Five of Biotech Showcase’s most interesting startups | Interestingly, none of these startups are located in the usual geographical suspects: Boston, San Francisco and San Diego. Aegle Therapeutics Corp. This regenerative medicine startup is developing microvesicles – that is, fragments of plasm... |
| - | Five of Biotech Showcase’s most interesting startups | Presenting at the J.P. Morgan Healthcare Conference may confer some level of credibility to a company – but several worthy startups are showcased each year at the neighboring Biotech Showcase. Some 300 biotechnology companies – public and p... |